EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Alejandra Zazueta, Lucía Valenzuela-Pérez iD, Nicolás Ortiz-López iD, Araceli Pinto-León, Verónica Torres, Danette Guiñez, Nicolás Aliaga, Pablo Merino, Alexandra Sandoval, Natalia Covarrubias, Edith Pérez de Arce, Máximo Cattaneo und 6 weitere

International Journal of Molecular Sciences · 16.04.2024 · 25 (8) · 4387

DOI: 10.3390/ijms25084387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.04.2024. Verfasst von Alejandra Zazueta und 17 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology and Mycology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago 8380453, Chile. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Investigación y Desarrollo, OFICINA DE APOYO A LA INVESTIGACION CLINICA (OAIC)-HCUCH, Temas Libres.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a complex disorder whose prevalence is rapidly growing in South America. The disturbances in the microbiota–gut–liver axis impact the liver damaging processes toward fibrosis. Gut microbiota status is shaped by dietary and lifestyle factors, depending on geographic location. We aimed to identify microbial signatures in a group of Chilean MASLD patients. Forty subjects were recruited, including healthy controls (HCs), overweight/obese subjects (Ow/Ob), patients with MASLD without fibrosis (MASLD/F−), and MASLD with fibrosis (MASLD/F+). Both MASLD and fibrosis were detected through elastography and/or biopsy, and fecal microbiota were analyzed through deep sequencing. Despite no differences in α- and β-diversity among all groups, a higher abundance of Bilophila and a lower presence of Defluviitaleaceae, Lachnospiraceae ND3007, and Coprobacter was found in MASLD/F− and MASLD/F+, compared to HC. Ruminococcaceae UCG-013 and Sellimonas were more abundant in MASLD/F+ than in Ow/Ob; both significantly differed between MASLD/F− and MASLD/F+, compared to HC. Significant positive correlations were observed between liver stiffness and Bifidobacterium, Prevotella, Sarcina, and Acidaminococcus abundance. Our results show that MASLD is associated with changes in bacterial taxa that are known to be involved in bile acid metabolism and SCFA production, with some of them being more specifically linked to fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeHumansMaleFemaleMiddle AgedAdultLiver CirrhosisFecesLiverFatty LiverDisease ProgressionObesityChileBacteriaAged

Stichwörter der Autor:innen

MASLDgut–liver axisintestinal microbiotaliver fibrosisobesity

Autor:innen und Institutionen

  • Microbiology and Mycology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago 8380453, Chile.
  • Laboratory of Immuno-Gastroenterology, Section of Gastroenterology, Department of Medicine, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
  • Unit of Gastroenterology, Department of Medicine, Hospital Clinico Universidad de Chile, Santiago 8380456, Chile.
  • Department of Nutrition, Faculty of Medicine, University of Chile, Santiago 8380453, Chile.

ORCID-Profile: Lucía Valenzuela-Pérez, Nicolás Ortiz-López, Martín Gotteland

Förderung

  • Agencia Nacional de Investigación y Desarrollo
  • OFICINA DE APOYO A LA INVESTIGACION CLINICA (OAIC)-HCUCH
  • Temas Libres

Zitieren

APA

Zazueta, A., Valenzuela-Pérez, L., Ortiz-López, N., Pinto-León, A., Torres, V., Guiñez, D., Aliaga, N., Merino, P., Sandoval, A., Covarrubias, N., Pérez de Arce, E., Cattaneo, M., Urzúa, A., Roblero, J. P., Poniachik, J., Gotteland, M., Magne, F., & Beltrán, C. J. (2024). Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). International Journal of Molecular Sciences, 25(8), 4387. https://doi.org/10.3390/ijms25084387

Vancouver

Zazueta A, Valenzuela-Pérez L, Ortiz-López N, Pinto-León A, Torres V, Guiñez D, et al. Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). International Journal of Molecular Sciences. 2024;25(8):4387. doi:10.3390/ijms25084387

BibTeX
@article{Zazueta2024,
  author = {Zazueta, Alejandra and Valenzuela-Pérez, Lucía and Ortiz-López, Nicolás and Pinto-León, Araceli and Torres, Verónica and Guiñez, Danette and Aliaga, Nicolás and Merino, Pablo and Sandoval, Alexandra and Covarrubias, Natalia and Pérez de Arce, Edith and Cattaneo, Máximo and Urzúa, Alvaro and Roblero, Juan Pablo and Poniachik, Jaime and Gotteland, Martín and Magne, Fabien and Beltrán, Caroll Jenny},
  title = {Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {8},
  pages = {4387},
  doi = {10.3390/ijms25084387}
}
Kostenlos starten →